MedPath

The Effects of Unstable Shoes on Chronic Low Back Pain

Not Applicable
Completed
Conditions
Low Back Pain
Interventions
Device: Unstable shoes (MBT)
Device: Sham intervention (Adidas shoes)
Registration Number
NCT01384071
Lead Sponsor
University Hospital, Geneva
Brief Summary

Some physicians, physiotherapists and nurses use or even suggest unstable shoes in cases of low back pain. No studies on the real effects of these shoes on low back pain in health care professions have been carried out and therefore as yet there is no real evidence of their effectiveness. Thus the investigators assume that wearing unstable shoes over a period of six weeks could reduce low back pain and functional disability due to the changes of the gait and posture and may increase the quality of life.

The purposes of this study are:

1. To evaluate the modifications of pain level, functional capacity and quality of life among individuals with moderate level of non-specific chronic low back pain after wearing unstable shoes.

2. To quantify biomechanical modifications of gait and posture.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Unstable shoes (MBT)Unstable shoes (MBT)MBT shoes (Masai Barefoot Technology, Switzerland)
Stable shoes (Adidas)Sham intervention (Adidas shoes)Adidas stable shoes (Adidas Bigroar2)
Primary Outcome Measures
NameTimeMethod
Change from baseline in low back pain at 6 weeksBaseline and 6 weeks

Low back pain level with the visual analogue scale (VAS) from 0 to 10;

Change from baseline in the Roland-Morris disability questionnaire at 6 weeksBaseline and 6 weeks

functional disability with the Roland-Morris disability questionnaire (this questionnaire has been validated in French as the Functional Disability Scale for the Assessment of Low Back Pain - Eifel)

Change from baseline in the EQ-5D quality of life questionnaire at 6 weeksBaseline and 6 weeks

Quality of life with the EQ-5D.

Secondary Outcome Measures
NameTimeMethod
Change from baseline in gait speed at 6 weeksBaseline and 6 weeks

Seft-selected gait speed

Change from baseline in balance performance at 6 weeksBaseline and 6 weeks

center of pressure speed in conditions :

* eyes opened and eyes closed

* stable and unstable surface

Change from baseline in ankle dorsiflexion during gait at 6 weeksBaseline and 6 weeks

Ankle dorsiflexion at initial contact during gait

Change from baseline in pelvis anteversion during gait at 6 weeksBaseline and 6 weeks

Mean pelvis anteversion during gait

Change from baseline in trunk anteversion during gait at 6 weeksBaseline and 6 weeks

Mean trunk anteversion during gait

Change from baseline in activation period of lower-limb muscles during gait at 6 weeksBaseline and 6 weeks

Activation period of lower-limb muscles (gasctrocnemius, peroneus, tibialis anterior, rectus femoris and semi-tendinosus) during gait

Change from baseline in activation period of erector spinae during gait at 6 weeksBaseline and 6 weeks

Activation period of erector spinae during gait

Change from baseline in maximum knee extension during gait stance phase at 6 weeksBaseline and 6 weeks

Maximum knee extension during stance phase

Trial Locations

Locations (1)

University Hospitals of Geneva

🇨🇭

Geneva, Switzerland

© Copyright 2025. All Rights Reserved by MedPath